Bayesian Capital Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,900	Closed	-$1.29M	–	829
2025 Q2	$1.29M	Buy	+5,900	New	+$1.26M	0.2%	146
2025 Q1	–	Sell	-10,500	Closed	-$3.44M	–	1008
2024 Q4	$3.44M	Buy	+10,500	New	+$3.3M	0.42%	60
2024 Q1	–	Sell	-909	Closed	-$320K	–	1160
2023 Q4	$320K	Buy	909 +281	+45%	+$99.4K	0.03%	488
2023 Q3	$236K	Buy	+628	New	+$243K	0.03%	523
2023 Q2	–	Sell	-6,000	Closed	-$2.08M	–	1094
2023 Q1	$2.08M	Buy	+6,000	New	+$1.75M	0.26%	106
2021 Q4	–	Sell	-1,197	Closed	-$508K	–	539
2021 Q3	$508K	Buy	+1,197	New	+$505K	0.15%	186
2021 Q2	–	Sell	-845	Closed	-$238K	–	677
2021 Q1	$238K	Sell	845 -4,455	-84%	-$1.28M	0.05%	412
2020 Q4	$1.5M	Sell	5,300 -700	-12%	-$196K	0.39%	64
2020 Q3	$1.65M	Sell	6,000 -1,378	-19%	-$365K	0.4%	55
2020 Q2	$1.68M	Buy	7,378 +5	+0.1%	+$982	0.37%	56
2020 Q1	$1.12M	Sell	7,373 -1,972	-21%	-$304K	0.24%	102
2019 Q4	$1.41M	Buy	9,345 +3,500	+60%	+$510K	0.24%	113
2019 Q3	$829K	Buy	+5,845	New	+$805K	0.16%	185
2018 Q1	–	Sell	-12,400	Closed	-$1.22M	–	845
2017 Q4	$1.22M	Buy	+12,400	New	+$1.22M	0.25%	129
2017 Q3	–	Sell	-6,710	Closed	-$634K	–	668
2017 Q2	$634K	Buy	+6,710	New	+$617K	0.23%	148